Page last updated: 2024-08-26

artenimol and Carcinoma, Ductal

artenimol has been researched along with Carcinoma, Ductal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Habibi, Z; Hassan, ZM; Noori, S; Rezaei, B; Taghikhani, M	1

Other Studies

1 other study(ies) available for artenimol and Carcinoma, Ductal

Article	Year
Dihydroartemisinin can inhibit calmodulin, calmodulin-dependent phosphodiesterase activity and stimulate cellular immune responses. International immunopharmacology, 2010, Volume: 10, Issue:2 Topics: Animals; Antineoplastic Agents; Artemisinins; Calmodulin; Carcinoma, Ductal; Cyclic Nucleotide Phosphodiesterases, Type 1; Erythrocytes; Female; Hypersensitivity, Delayed; Immunity, Cellular; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C	2010

Article

Year

Dihydroartemisinin can inhibit calmodulin, calmodulin-dependent phosphodiesterase activity and stimulate cellular immune responses.

International immunopharmacology, 2010, Volume: 10, Issue:2

Topics: Animals; Antineoplastic Agents; Artemisinins; Calmodulin; Carcinoma, Ductal; Cyclic Nucleotide Phosphodiesterases, Type 1; Erythrocytes; Female; Hypersensitivity, Delayed; Immunity, Cellular; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C

2010